These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Isoniazid and rifampicin rarely cause acute pancreatitis in patients with tuberculosis. Chan TY Int J Clin Pharmacol Ther; 1999 Feb; 37(2):109. PubMed ID: 10082175 [No Abstract] [Full Text] [Related]
66. [Primary resistance in adult pulmonary tuberculosis in France. 3d report of the study center on Primary Resistance: 1966-1970]. Canetti G; Le Lirzin M; Gay P; Thibier R; Kreis B; Grosset J Rev Tuberc Pneumol (Paris); 1972; 36(3):337-56. PubMed ID: 5080965 [No Abstract] [Full Text] [Related]
67. [Severe hypersensitivity to SM, INH and PAS in a child with post-primary tuberculosis]. Rykowska Z Gruzlica; 1969 Aug; 37(8):777-81. PubMed ID: 4242816 [No Abstract] [Full Text] [Related]
68. [Ethambutol combined with streptomycin and isoniazid for the original treatment cases of pulmonary tuberculosis]. Donomae I; Fujita S; Gomi J; Hayashi N; Hibino S Kekkaku; 1970 Feb; 45(2):55-60. PubMed ID: 5439133 [No Abstract] [Full Text] [Related]
69. Adverse effects of antitubercular drugs and significance of measurement of the drug-stimulating lymphocyte transformation rate. Umeki S Jpn J Med; 1989; 28(3):335-40. PubMed ID: 2739142 [TBL] [Abstract][Full Text] [Related]
70. Incidence of drug hypersensitivity in the chemotherapy of tuberculosis. Govindaraj M; Grant LJ Br J Dis Chest; 1968 Jan; 62(1):27-31. PubMed ID: 5656836 [No Abstract] [Full Text] [Related]
72. Ethambutol: a substitute for para-aminosalicylic acid in regimens for pulmonary tuberculosis. Ferebee SH; Doster BE; Murray FJ Ann N Y Acad Sci; 1966 Apr; 135(2):910-20. PubMed ID: 5220246 [No Abstract] [Full Text] [Related]
73. Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy. Roman IC; Vainer E; Socosan I; Drăghicescu T Hum Genet; 1983; 63(2):191-2. PubMed ID: 6840764 [TBL] [Abstract][Full Text] [Related]
74. [Side-effects in chemotherapy of pulmonary tuberculosis]. Savula MM; Smachilo DT; Kiselova ES Probl Tuberk; 1976 Feb; (21):39-43. PubMed ID: 1264981 [No Abstract] [Full Text] [Related]
75. Comparison of ethambutol-INH versus INH-PAS in original treatment of pulmonary tuberculosis. Bobrowitz ID Ann N Y Acad Sci; 1966 Apr; 135(2):921-39. PubMed ID: 5220247 [No Abstract] [Full Text] [Related]
76. [Allergy to antitubercular agents; with special reference to new drugs]. Mühlberger F Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096 [No Abstract] [Full Text] [Related]
77. [Surveillance and complications of antituberculosis chemotherapy]. Duroux P Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779 [No Abstract] [Full Text] [Related]
79. Effects of age, sex and alcoholic habit of patients on liver enzymes during antituberculosis chemotherapy. Aggarwal NP; Kallan BM; Aggarwal M; Joshi R J Indian Med Assoc; 1991 Nov; 89(11):311-2. PubMed ID: 1787318 [No Abstract] [Full Text] [Related]
80. Adverse reactions to drugs used in the treatment of tuberculosis. Nariman S Adverse Drug React Acute Poisoning Rev; 1988; 7(4):207-27. PubMed ID: 3071113 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]